high-level resistance when the MIC was ≥256 μg/mL. A PCR for detection of the vanA or vanB genotype was used (7) . Isolates were characterized by pulsed-fi eld gel electrophoresis (PFGE) (8, 9) ; a dendrogram was constructed with the GelCompare II 4.0 software (Applied Maths, Kortrijk, Belgium), and the similarity was compared with the Dice coeffi cient.
In the study period, VREF was isolated from 27 patients. The median age was 40 years (range 22-84 years). VREF was isolated from the abdomen in 14 patients (51.9%); 11 isolates were from an abscess, 2 from infected surgical sites, and 1 from ascites. An additional 8 isolates were from the urinary tract (29.6%), 2 from the bloodstream (7.4%), 2 from soft-tissue (7.4%), and 1 (3.7%) from bone. Residence in the general medical wards during the isolation of VREF was most common, 17 (63%) cases, followed by 6 (22.2%) in the intensive care unit. The remaining 4 (14.8%) were distributed in other areas. Median time of hospitalization before the isolation was 21 days (range 1-84 days). PFGE analysis showed several genotypes of E. faecium; however, 18 of 26 of the isolates had <3 band differences from the predominant strain classifi ed as type A. One isolate of E. faecium could not be typed (Figure) .
As in most tertiary-care centers, our PFGE data suggest that a heterogenous population of VREF exists, but a particular clone established itself as the dominant strain. Although infection control measures are well established in our hospital, in disseminated outbreaks caused by several different clones, infection control measures and control of vancomycin use have shown only limited effi cacy. This suggests selection pressure by antimicrobial drugs other than vancomycin (10) . Early detection of VREF is of extreme importance because of the possibility that the vanA gene may be transferred to a variety of gram-positive microorganisms, including S. aureus.
The rate of isolation of VREF at our hospital increased considerably during the last year. Even though the number of patients is small, we consider this fi nding to be of utmost importance, since VREF seems to be emerging in Mexico. To our knowledge, this is the fi rst well-documented outbreak of high-level resistance to vancomycin in enterococci in Mexico. Further research is needed to determine if the problem is limited to our hospital or if it is a nationwide trend.
